Medicine and Dentistry
Neoplasm
100%
Cancer
72%
Diseases
63%
Tumor Necrosis Factor
50%
Peritoneum Mesothelioma
49%
Liver Metastasis
48%
Surgery
44%
Metastatic Carcinoma
37%
Melphalan
37%
Malignant Neoplasm
32%
Oncologist
32%
Melanoma
28%
Mesothelioma
26%
Colorectal Carcinoma
26%
Gastrinoma
25%
Zollinger-Ellison Syndrome
25%
Limb Perfusion
22%
Reoperation
20%
Symptomatic Treatment
19%
Hyperparathyroidism
19%
Primary Hyperparathyroidism
19%
Gene Expression
18%
Overall Survival
17%
Cytoreductive Surgery
17%
Neuroendocrine Tumor
17%
Nesidioblastosis
16%
Multiple Endocrine Neoplasia Type I
15%
Awareness
15%
Parathyroid Adenoma
15%
Pathologist
14%
Cytokine
13%
Pancreas Islet Cell Tumor
13%
Cisplatin
13%
Pancreas Cancer
13%
Eye Melanoma
13%
Vaccinia Virus
12%
Prospective Study
12%
Hyperthermic Intraperitoneal Chemotherapy
12%
Endothelial Cell
12%
Hyperthermia
12%
Parathyroid
11%
Pancreas Adenocarcinoma
11%
Adenoma
11%
Peritoneum
10%
Limb
10%
Parathyroid Hormone
10%
Parathyroid Gland
10%
Magnetic Resonance Imaging
9%
Regional Perfusion
9%
Drug Megadose
9%
Keyphrases
Tumor Necrosis Factor-α
73%
Tumor
72%
Isolated Hepatic Perfusion
45%
Hyperthermia
41%
Liver
38%
Melphalan
35%
Peritoneal Surface Malignancy
34%
Chicago
32%
Liver Metastasis
30%
Malignant Peritoneal Mesothelioma
28%
Zollinger-Ellison Syndrome
26%
Peritoneal Mesothelioma
25%
Mesothelioma
23%
Isolated Limb Perfusion
22%
Multiple Endocrine Neoplasia Type 1 (MEN1)
21%
Resection
21%
Reoperation
20%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
20%
Gastrinoma
20%
Perfusion
18%
Cytoreductive Surgery
17%
Interleukin-1β
17%
Enhanced Awareness
16%
Hyperparathyroidism
16%
Surgical Oncologist
16%
Radiologists
16%
Peritoneal Surface Disease
15%
Pathologist
15%
Appropriate Management
15%
Medical Oncologist
15%
Pharmacist
15%
Palliative Care Physicians
15%
Insulinoma
15%
Peritoneal Perfusion
15%
Cisplatin
15%
Parathyroid Adenoma
14%
Pancreatic Cancer
14%
Vaccinia Virus
14%
Surgical Resection
14%
Gene Expression
14%
Ocular Melanoma
12%
Metastasis
12%
Endostatin
12%
Endothelial Monocyte-activating polypeptide-II
12%
Pancreatic Ductal Adenocarcinoma
12%
Colorectal Cancer
12%
Overall Survival
12%
Peritoneum
12%
Tumor Growth
11%
Melanoma
11%